BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 18460007)

  • 1. History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
    Tfelt-Hansen PC; Koehler PJ
    Cephalalgia; 2008 Aug; 28(8):877-86. PubMed ID: 18460007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine: current perspectives.
    Young WB
    Headache; 1997; 37 Suppl 1():S42-5. PubMed ID: 9009473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early use of ergotamine in migraine. Edward Woakes' report of 1868, its theoretical and practical background and its international reception.
    Koehler PJ; Isler H
    Cephalalgia; 2002 Oct; 22(8):686-91. PubMed ID: 12383066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
    Lipton RB
    Headache; 1997; 37 Suppl 1():S33-41. PubMed ID: 9009472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
    Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
    Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment guidelines for acute migraine attacks].
    Treatment Guideline Subcommittee of Taiwan Headache Society
    Acta Neurol Taiwan; 2007 Dec; 16(4):251-68. PubMed ID: 18220021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
    Silberstein SD; McCrory DC
    Headache; 2003 Feb; 43(2):144-66. PubMed ID: 12558771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ergot of rye-the first specific for migraine.
    Eadie MJ
    J Clin Neurosci; 2004 Jan; 11(1):4-7. PubMed ID: 14642357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Mathew NT
    Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment.
    Tfelt-Hansen P
    Headache; 2008 Apr; 48(4):601-5. PubMed ID: 18377382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute treatment of migraine.
    Tepper SJ; Spears RC
    Neurol Clin; 2009 May; 27(2):417-27. PubMed ID: 19289223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergotamine and dihydroergotamine: a review.
    Bigal ME; Tepper SJ
    Curr Pain Headache Rep; 2003 Feb; 7(1):55-62. PubMed ID: 12525272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of ergotamine and dihydroergotamine.
    Silberstein SD
    Headache; 1997; 37 Suppl 1():S15-25. PubMed ID: 9009470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-HT
    Whealy M; Becker WJ
    Handb Clin Neurol; 2024; 199():17-42. PubMed ID: 38307644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine: pathophysiology, pharmacology, treatment and future trends.
    Villalón CM; Centurión D; Valdivia LF; de Vries P; Saxena PR
    Curr Vasc Pharmacol; 2003 Mar; 1(1):71-84. PubMed ID: 15320857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Migrane treatment in the Netherlands in the early twentieth century].
    Koehler PJ; Bruyn GW
    Ned Tijdschr Geneeskd; 1998 Sep; 142(36):2009-13. PubMed ID: 9856202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroergotamine: role in the treatment of migraine.
    Schürks M
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transient global amnesia following the use of ergots in the treatment of migraine].
    Gil-Martínez T; Galiano R
    Rev Neurol; 2004 Nov 16-30; 39(10):929-31. PubMed ID: 15573308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of clinical trials using early acute intervention with oral triptans for migraine management.
    Dowson AJ; Mathew NT; Pascual J
    Int J Clin Pract; 2006 Jun; 60(6):698-706. PubMed ID: 16805756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of ischemic complications related to the intensity of triptan and ergotamine use.
    Wammes-van der Heijden EA; Rahimtoola H; Leufkens HG; Tijssen CC; Egberts AC
    Neurology; 2006 Oct; 67(7):1128-34. PubMed ID: 17030745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.